WEX Pharmaceuticals Inc:企業の戦略的SWOT分析

◆英語タイトル:WEX Pharmaceuticals Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15784
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

WEX Pharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

WEX Pharmaceuticals Inc (WEX), a subsidiary of CK Life Sciences Int’l., (Holdings) Inc., is a clinical stage biotechnology company that focuses on the discovery, development, manufacture and commercialization of drugs for pain management. The company develops a new class of non-opioid analgesics utilizing its proprietary platform technology TTX (Tetrodotoxin or TTX). TTX is a non-peptide neurotoxin, non-addictive alternative to opioids, and a sodium channel blocker. WEX’s clinical candidates include TEC-006 and TTX-CINP-201. TEC-006 is being studied for the treatment of moderate to severe cancer related pain and TTX-CINP-201 is being developed for moderate to severe neuropathic pain caused by chemotherapy in patients with cancer. WEX is headquartered in Vancouver, British Columbia, Canada.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
WEX Pharmaceuticals Inc – Key Facts
WEX Pharmaceuticals Inc – Key Employees
WEX Pharmaceuticals Inc – Key Employee Biographies
WEX Pharmaceuticals Inc – Major Products and Services
WEX Pharmaceuticals Inc – History
WEX Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
WEX Pharmaceuticals Inc – Business Description
WEX Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
WEX Pharmaceuticals Inc – Strengths
WEX Pharmaceuticals Inc – Weaknesses
WEX Pharmaceuticals Inc – Opportunities
WEX Pharmaceuticals Inc – Threats
WEX Pharmaceuticals Inc – Key Competitors
Section 3 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
WEX Pharmaceuticals Inc, Key Facts
WEX Pharmaceuticals Inc, Key Employees
WEX Pharmaceuticals Inc, Key Employee Biographies
WEX Pharmaceuticals Inc, Major Products and Services
WEX Pharmaceuticals Inc, History
WEX Pharmaceuticals Inc, Key Competitors

★海外企業調査レポート[WEX Pharmaceuticals Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mitsui O.S.K. Lines Ltd (9104):企業の財務・戦略的SWOT分析
    Mitsui O.S.K. Lines Ltd (9104) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • A2A SpA:企業のM&A・提携・投資分析
    A2A SpA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's A2A SpA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Gore Mutual Insurance Company:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Gore Mutual Insurance Company" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric stri …
  • Insurance Australia Group Limited:企業のM&A・提携・投資分析
    Insurance Australia Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Insurance Australia Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Banco do Brasil S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Banco do Brasil S.A. Mergers an …
  • Catasys, Inc. (CATS)(製薬・医療分野):企業M&A動向
    Summary Catasys, Inc. (Catasys) is a healthcare service provider. The company provides health management services to health plans, employers and unions through a network of licensed and company managed health care providers. Its OnTrak integrated substance dependence program is designed to address s …
  • EffRx Pharmaceuticals SA:製薬・医療:M&Aディール及び事業提携情報
    Summary EffRx Pharmaceuticals SA (EffRx), formerly EffRx Inc is a pharmaceutical company that develops and commercializes prescription medications for specialty indications. The company offers therapeutics for men and women with musculoskeletal, genitourinary and endocrine disorders. It provides com …
  • DFDS A/S:企業の戦略・SWOT・財務分析
    SummaryDFDS A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - Det …
  • Emerald Resources NL (EMR):企業の財務・戦略的SWOT分析
    Summary Emerald Resources NL (Emerald) is an oil and gas company that carries out mineral exploration and development. The company carries out acquisition, exploration, development and produces oil and natural gas, and gold deposits. Its projects include Okavu Gold project, and Magoffin County proje …
  • Fidelity Investments, Inc.:企業のM&A・提携・投資分析
    Fidelity Investments, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fidelity Investments, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Immersion Corporation (IMMR):企業概要、財務及び戦略的SWOT分析
    Summary Immersion Corporation (Immersion) is a haptic technologies provider. The company develops and advertises or licenses software technologies and products. It provides touchsense engage software solution, touchsense tactile feedback, integrator for OEMS, haptic SDK for developers and touchsense …
  • Vitasoy International Holdings Limited:企業の戦略・SWOT・財務情報
    Vitasoy International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Vitasoy International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Celltrion Inc (068270):企業の財務・戦略的SWOT分析
    Celltrion Inc (068270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • WCP Resources Limited (WCP):企業概要、財務及び戦略的SWOT分析
    Summary WCP Resources Limited (WCP) is a mineral exploration company. The company acquires, explores and develops gold deposits. Its Al Hariqah gold project is located in the Northwest of Sana'a in Republic of Yemen. WCP’s Al Hariqah project covers 957 square kilo meters of area. The company conduct …
  • Pentair plc:企業の戦略・SWOT・財務分析
    SummaryPentair plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Heron Resources Limited:企業の戦略・SWOT・財務分析
    SummaryHeron Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Ikaria, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ikaria, Inc. Mergers and Acquis …
  • Laredo Petroleum, Inc. (LPI):企業のM&A・提携動向(石油・ガス分野)
    Summary Laredo Petroleum, Inc. (Laredo) is an independent upstream oil and gas company. The company acquires assets, and explores for, develops and produces oil and gas. It focuses on drilling to discover oil and liquids-rich natural gas. It has operations in the Permian Basin, which consists of two …
  • SSP Offshore, Inc. (formerly OPE Holdings, Ltd.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SSP Offshore, Inc. (formerly OP …
  • Uponor Oyj:企業の戦略・SWOT・財務情報
    Uponor Oyj - Strategy, SWOT and Corporate Finance Report Summary Uponor Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆